MRI as a virtual biopsy for prostate cancer detection
Almudena Fuster
Prostate cancer (PCa) is the second most frequent malignancy in men worldwide, accounting for 1,414,259 new cases and causing around…
Read More
Prostate cancer (PCa) is the second most frequent malignancy in men worldwide, accounting for 1,414,259 new cases and causing around…
Read More
The range of therapeutic options for cancer treatment along the patient journey is diverse, including surgery, radiation therapy, chemotherapy, hormone…
Read More
Amid spatial biology’s momentum, imaging is one of the key promising techniques for the visualization and treatment response assessment of…
Read More
Colorectal cancer (CRC) is one of the most common cancers diagnosed nowadays, as it is estimated that 1 in 24…
Read More
As Quibim, we are flattered to take part of the Italian Medical Physics Association (AIFM) webinar event that took place…
Read More
· Global leader in medical imaging analysis Quibim has joined Highlight Therapeutics, a clinical-stage company specializing in immuno-oncology, to assess…
Read More
Allows early detection of COVID-19 by radiologists through imaging biomarkers and is the main AI platform for screening for the…
Read More
Quibim is helping to advance knowledge of the most lethal pediatric tumors through EU-funded program PRIMAGE, which exploits precision information from medical…
Read More
Pain, depression, slurred speech and feeling of numbness, tingling, or weakness. These are just some symptoms of Multiple Sclerosis (MS) disease, a…
Read More